Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Georg, Boelke"'
Autor:
Georg Boelke, Uwe Berger, Karl-Christian Bergmann, Carsten Bindslev-Jensen, Jean Bousquet, Julia Gildemeister, Marek Jutel, Oliver Pfaar, Torsten Sehlinger, Torsten Zuberbier
Publikováno v:
Clinical and Translational Allergy, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Background The GA2LEN chamber has been developed as a novel mobile allergen exposure chamber (AEC) allowing standardized multicenter trials in allergy. Hitherto, subjective nasal symptom scores have been the most often used outcome parameter
Externí odkaz:
https://doaj.org/article/fac276b4d622420c9ef20fcd4593e602
Autor:
Torsten Zuberbier, Georg Boelke, Karl-Christian Bergmann, Joseph Salamé, Julia Gildemeister, Frank Goergen, Torsten Voegler
Publikováno v:
Allergo Journal. 26:20-27
Field trials are the traditional approach for clinical trials in allergy but are under criticism for lack of standardization as they are affected by uncontrollable parameters such as environmental conditions, pollen counts, or lifestyle. Stationary a
Autor:
Oliver Pfaar, Enzo Madonini, Torsten Zuberbier, Nikolaos G. Papadopoulos, Giorgio Walter Canonica, Georg Boelke, Cezmi A. Akdis, Claus Bachert, Jean Bousquet, Marek Jutel, Uwe Berger, Marek L. Kowalski, Mark B. Abelson, Carsten Bindslev-Jensen, Thomas B. Casale, Torsten Sehlinger, Karl-Christian Bergmann
Publikováno v:
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Zuberbier, T, Abelson, M B, Akdis, C A, Bachert, C, Berger, U, Bindslev-Jensen, C, Boelke, G, Bousquet, J, Canonica, G W, Casale, T B, Jutel, M, Kowalski, M L, Madonini, E, Papadopoulos, N G, Pfaar, O, Sehlinger, T, Bergmann, K-C & GALEN EU Network of Excellence in Allergy and Asthma 2017, ' Validation of the Global Allergy and Asthma European Network (GA 2 LEN) chamber for trials in allergy : Innovation of a mobile allergen exposure chamber ', Journal of Allergy and Clinical Immunology, vol. 139, no. 4, 1158–1166, pp. 1158-1166 . https://doi.org/10.1016/j.jaci.2016.08.025
Zuberbier, T, Abelson, M B, Akdis, C A, Bachert, C, Berger, U, Bindslev-Jensen, C, Boelke, G, Bousquet, J, Canonica, G W, Casale, T B, Jutel, M, Kowalski, M L, Madonini, E, Papadopoulos, N G, Pfaar, O, Sehlinger, T, Bergmann, K-C & GALEN EU Network of Excellence in Allergy and Asthma 2017, ' Validation of the Global Allergy and Asthma European Network (GA 2 LEN) chamber for trials in allergy : Innovation of a mobile allergen exposure chamber ', Journal of Allergy and Clinical Immunology, vol. 139, no. 4, 1158–1166, pp. 1158-1166 . https://doi.org/10.1016/j.jaci.2016.08.025
Background Field clinical trials of pollen allergy are affected by the impossibility of predicting and determining individual allergen exposure because of many factors (eg, pollen season, atmospheric variations, pollutants, and lifestyles). Environme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c284db821a704020f08fd0ddbdd60a8d
https://biblio.ugent.be/publication/8513650
https://biblio.ugent.be/publication/8513650
Autor:
Torsten, Zuberbier, Mark B, Abelson, Cezmi A, Akdis, Claus, Bachert, Uwe, Berger, Carsten, Bindslev-Jensen, Georg, Boelke, Jean, Bousquet, Giorgio Walter, Canonica, Thomas B, Casale, Marek, Jutel, Marek L, Kowalski, Enzo, Madonini, Nikolaos G, Papadopoulos, Oliver, Pfaar, Torsten, Sehlinger, Karl-Christian, Bergmann
Publikováno v:
The Journal of allergy and clinical immunology. 139(4)
Field clinical trials of pollen allergy are affected by the impossibility of predicting and determining individual allergen exposure because of many factors (eg, pollen season, atmospheric variations, pollutants, and lifestyles). Environmental exposu